Platelets produce platelet growth factors such as PDGF, IGF-1, EGF-, HGF, TGFβ, bFGF, and
VEGF, which are crucial in regulating all stages of the wound healing process. The source of …

Premature ovarian insufficiency (POI) occurs in at least 1% of all women and causes life-
long health problems and psychological stress. Infertility caused by POI used to be …

Purpose Platelet-rich plasma (PRP) has become a novel treatment in various aspects of
medicine including orthopedics, cardiothoracic surgery, plastic surgery, dermatology …

The ovary is the first organ to age in humans with functional decline evident already in
women in their early 30s. Reproductive aging is characterized by a decrease in oocyte …

Primary ovarian insufficiency (POI) is a rare gynecological condition. This disease causes
menstrual disturbances, infertility, and various health problems. Historically, hormone …

Purpose Platelet-rich plasma (PRP) therapy has been used as an adjunct to fertility
treatments in women with very low ovarian reserve and premature ovarian insufficiency …

The prospect of ovarian rejuvenation offers the tantalising prospect of treating age-related
declines in fertility or in pathological conditions such as premature ovarian failure. The …

Ferroptosis is widely present in fibrosis-related diseases. The basic pathology of premature
ovarian insufficiency (POI) involves ovarian tissue fibrosis, and there are currently fewer …

The aim of the current study was to characterize ovarian reserve parameters and IVF
outcomes in women with a history of poor ovarian response (POR) treated with intraovarian …

Injection of intraovarian platelet-rich plasma (PRP) was recently presented in terms of
improvement ovarian function in women with a poor ovarian response (POR) or primary …